Rheumatoid Arthritis
Pyrimethamine effective second-line treatment against rheumatoid arthritis
Published in Immunotherapy Weekly, November 2nd, 2005
"Recent evidence has shown that the antimalarials are useful drugs in the treatment of various rheumatic diseases. The present study was designed to test the therapeutic effect of pyrimethamine (PYR) in collagen-induced arthritis (CIA)," explained F. Saadat and associates at Tehran University of Medical Science in a recent issue of the journal Medical Science Monitor.
The researchers reported, "CIA was induced in Lewis rats. The intraperitoneal administration of PYR and methotrexate (MTX) were started on day 25 post-immunization and continued until final assessment on day...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2005-11-02)
More Articles from Immunotherapy Weekly
- Immunotherapy
Cannabinoids can modulate function and secretion of cytokines from immune cells - Immunotherapy
Immune therapy could treat leukemias, autoimmune diseases, transplant rejection - Immunotherapy
Modifying T cells with chimeric NKG2D receptors appears to be a promising cancer immunotherapy - Meningitis Vaccine
CD14 deficiency leads to early death in pneumococcal infections - Allergy & Immunology
E.U. research project will address food allergies - Alzheimer Disease
Researchers sniff out a novel therapy for AD using compounds already in use - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
